Close

Hollister Biosciences Inc.’s Division Hollister Cannabis Co. Launches Tommy Chong’s Cannabis 1:1 Full-Spectrum Elixir

VANCOUVERMay 27, 2020 – Hollister Biosciences Inc. (CSE: HOLLFRANKFURTHOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce the tincture it is manufacturing and distributing for its partner, Tommy Chong’s Cannabis, is officially ready to hit the market.

The tincture, branded Tommy Chong’s Cannabis™ 1:1 Full Spectrum Elixir, features a sweet berry flavor and 1:1 ratio of CBD to THC; for a total of 1000mg cannabinoids (500mg CBD and 500mg THC). True to the manufacturing mission of Hollister Cannabis Co., this 1:1 tincture was crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis. 

The tincture, Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1, is being distributed exclusively by Hollister Cannabis Co.’s distribution partner, Indus Holdings, Inc. (CSE: INDS)

CEO of Hollister Biosciences, Carl Saling, shared: “We are thrilled to have Tommy Chong’s Full Spectrum Elixir at Indus’ distribution center, ready to distribute to dispensaries in California. I am super proud of our team – especially through this global pandemic. We have continued to push forward and release a legendary product for a true legend!”

About Tommy Chong’s Cannabis: 

As one-half of the legendary comedy duo Cheech & Chong, Tommy Chong helped pioneer a completely unique brand of comedy directed at the counterculture movement of the early ’70s. At the heart of this brand of entertainment was cannabis. On-screen and off Tommy became a vocal advocate for his favorite herb. In a time where cannabis had to be talked about in whispers, Tommy was a loud voice for the advocacy movement, working tirelessly to destigmatize the use of this healing plant. With the legalization of recreational cannabis, Tommy’s voice continues to ring out loudly, touting its benefits and place in society. Now, Tommy is thrilled to share that passion and knowledge of cannabis with the rest of the world. Using his lifelong connections in the industry, he has made it his personal mission to share the very best product available with his fans and fellow herb connoisseurs. If anyone knows weed, it’s Tommy. And now fans of comedy and cannabis alike can experience the strains and products that Tommy himself has hand-selected.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

“Carl Saling”

CEO and Director

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

For further information: please contact the Company at: Email: klee@k2capital.ca. Tel: 604-961-0296